Attrition along the cascade of HIV care compromises attainment of the UNAIDS 90-90-90 goals and achievement of desirable treatment outcomes for people living with HIV. Given known gender disparities in HIV care and outcomes, understanding the correlates of attrition at stages of the care cascade for women living with HIV (WLWH) is essential. Among the 1425 WLWH enrolled in the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS), we measured the proportion who reported not being currently on combination antiretroviral therapy (cART) and the proportion who reported a detectable viral load (VL; ‡40 copies/mL) despite cART use. Correlates of these cascade indicators were examined using univariate and multivariable logistic regression. Overall, 14.8% of women were not currently on cART. Of women who were on cART, 9.0% were not virally suppressed. In multivariable analyses, age between 26 and 34, unstable housing, food insecurity, current injection drug use, higher HIV-related stigma, and racial discrimination were associated with increased odds of not being on cART. Factors associated with increased odds of reporting a detectable VL among women on cART included age £34 years, less than a secondary education, unstable housing, and incarceration in the previous year. Programmatic efforts to support cART use and viral suppression for WLWH in Canada should focus on social determinants of health, including housing and food insecurity, social exclusion, and education.
Introduction

F
or the benefits of combination antiretroviral therapy (cART) to be realized, people living with HIV (PLWH) must be fully engaged along the cascade of care-a continuum of care from the time of diagnosis to the provision of cART to ensure viral suppression. 1, 2 The use of cART, with sustained viral load (VL) suppression, is associated with an exceedingly low risk of transmission; 3 the concept of ''Treatment as Prevention (TasP)'' has been widely supported by several studies and mathematical modeling [4] [5] [6] [7] [8] and is becoming more commonplace with the rise in pre-and postexposure prophylaxis (PrEP and PEP). 9 Incomplete engagement at any stage of the cascade will compromise the full benefits of cART at both the individual and societal level, and will result in increased risk of HIV-related morbidity, mortality, and transmission. 10 Thus, disparities in cART prescription, uptake and adherence, and subsequent VL suppression are of paramount importance and have been prioritized by UNAIDS in their 90-90-90 objectives. 11 Women comprise 50% of all PLWH worldwide, and a growing body of evidence reveals marked gender disparities along the cascade of care. [12] [13] [14] [15] [16] [17] [18] [19] [20] Recent data from the United States show that while a larger percentage of women living with HIV (WLWH) are retained in care compared with men, a smaller percentage are on cART and are virally suppressed. 13, 14 Similar findings have emerged from Canada that demonstrate women are less likely than men to be engaged along all aspects of the cascade of care. [15] [16] [17] [18] [19] While it appears as though overall engagement in the cascade is improving with time for both men and women, attrition at each stage of the care cascade continues. 21, 22 Few studies have focused on barriers to cART use among women specifically. There are ethnoracial disparities in cART use; in the United States, women of Hispanic or black ethnicities are significantly less likely to be using cART than white/Caucasian women. 12, 13, [23] [24] [25] WLWH also experience more psychosocial barriers to cART use, including stigma, depression, substance, and alcohol use. 23, 26, 27 A large body of research has confirmed that the absence of health insurance compromises access to HIV care in the United States, including access to cART. [28] [29] [30] Prior studies have shown similar barriers to VL suppression for WLWH. 12, 13 Barriers have been reported along social inequities, 12 among those of younger age, 12, 13 with lower levels of education, 21 and among those lacking financial resources. 12 Psychosocial barriers precluding VL suppression include depression, substance use, and incarceration. 12 In Canada, women's lack of access to cART has primarily been examined among women who experience marginalization, including women who inject drugs and women involved in sex work. 15, 31 There are limited studies looking at the broader sociodemographic profile and barriers of cART access and VL suppression among WLWH in a setting with universal access to healthcare. The purpose of this study was to determine the proportion of Canadian WLWH who are currently not on cART, and who report a detectable VL despite cART use among a large sample of women participating in a national study. Secondly, we aimed to identify factors associated with not currently being on cART and factors associated with having a detectable VL among Canadian women who were taking cART.
Methods
Study population and design
This study utilized baseline data collected between August 2013 and May 2015 from 1425 WLWH participating in the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS), a community-based, participatory, and prospective cohort study of WLWH from Ontario, Quebec, and British Columbia. 32 The overall inclusion criteria were as follows: (1) self-identifying as a woman (transinclusive), (2) living with HIV, (3) being 16 years of age or older, and (4) living in Ontario, British Columbia or Quebec. For this analysis, we further restricted the inclusion criteria to women who answered the question on cART use (current or prior) (n = 1382).
Data collection
WLWH, who were trained as peer research associates (PRAs), recruited self-identified WLWH aged 16 years or older from one of the three study provinces. Purposive, nonrandom, and venue-based sampling methods, including word-of-mouth and online (e.g., Listservs for WLWH) methods, were used to recruit participants. Participants were recruited from AIDS service organizations (ASOs), HIV clinics, community-based organizations (CBOs), and ethnoracial-specific ASOs and CBOs. PRAs then administered a 90-min structured, online questionnaire either inperson (e.g., home, HIV clinic) or by phone/Skype for rural or remotely located participants. A $50 honorarium was given for participation.
Ethics approval was obtained from the respective Research Ethics Boards (REBs) of Women's College Hospital, Simon Fraser University and the University of British Columbia/ Providence Health, and McGill University Health Centre. Study sites with independent REBs obtained their own approval before commencing enrolment. All participants gave informed consent before commencing the survey.
Outcome variables
Participants who reported ever accessing HIV medical care were asked about their history of cART use and categorized as never having used cART, used cART previously but not currently, and currently using cART. For the purpose of this analysis, those reporting previously but not currently using cART (n = 67) and never using cART (n = 137) were categorized as not currently using cART (n = 204) and compared with those who reported currently being on cART (n = 1178). Participants who reported ever accessing HIV medical care were asked about their most recent VL, categorized as undetectable (<40 copies/mL), detectable ( ‡40 copies/mL), never received, do not know, or prefer not to answer (DK/ PNTA). Those who reported undetectable or detectable VLs were included in the analysis and compared (n = 1130). All DK/PNTA or missing responses were excluded.
Correlates of cART use and viral suppression We also explored the association between each outcome and various continuous scaled measures such as depression, social support, HIV-related stigma, racial discrimination, and gender discrimination. We determined score ranges and Cronbach's alpha for the analytic sample (n = 1382) who responded regarding cART use. Depression was measured using the 10-item Center for Epidemiologic Studies Depression (CES-D) (score range: 0-30; Cronbach's alpha = 0.88). 33 Social support was measured using the 4-item version of the Medical Outcomes Survey Social Support Survey (MOS-SSS; score range: 4-20 with higher scores indicating higher social support; Cronbach's alpha = 0.84). 34 HIV-related stigma was measured using the total score of the HIV Stigma Scale [35] [36] [37] (score range: 0-100 with higher scores indicating higher IV stigma; Cronbach's alpha = 0.84). Racial and gender discrimination were measured using two separate modified (8-item) versions of the 9-item Everyday Discrimination Scale (score range: 8-48 for both scales with higher scores indicating higher racial and gender discrimination; Cronbach's alpha = 0.96 for racism, 0.936 for sexism among cisgender women, and 0.949 for gender discrimination among transwomen and other gender-identified participants).
38,39
Statistical analyses
All outcomes and hypothesized factors associated with each outcome were described using medians and interquartile ranges (IQRs) for continuous variables and frequencies and proportions for categorical variables. In bivariable analyses, categorical variables were compared using the Pearson's chi-squared or Fisher's exact test, and continuous variables were compared using the Wilcoxon rank-sum test. Logistic regression was used to study the univariate and multivariate associations between the explanatory variables and each outcome (never or not currently using cART vs. currently using cART; not being virally suppressed vs. viral suppression). Factors significant at p < 0.05, as well as correlates chosen a priori, were considered for the multivariable model. Model selections were conducted using a backward stepwise technique based on the Type III p values and Akaike Information Criterion (AIC). The variable with the highest Type III p value was dropped at each step of the selection process until the model reached the lowest AIC (lower AIC indicates better model fit). All p values were two-sided and considered statistically significant at alpha = 0.05. Analyses were conducted using SAS version 9.4 (SAS, Cary, NC). 40 
Results
Participant sociodemographic and clinical characteristics
Overall, 85.2% (n = 1178/1382) of women were on cART, while 14.8% (n = 204/1382) of women were not currently receiving cART. Of those not receiving cART, 67.2% (n = 137/204) had never received cART, and 42.2% (n = 86/ 204) reported a CD4 T+ cell count of >500 cells/mm 3 . Table 1 summarizes the sociodemographic and clinical characteristics of women with complete data regarding cART use. The median age of women on cART was 44 (IQR 37-51) years versus 36 (IQR 32-44) years for those not on cART ( p < 0.001). The majority (96.3%) of women on cART selfidentified as cisgender versus 93.1% for those not on cART ( p = 0.04). Similarly, 88.4% of women on cART selfidentified as heterosexual versus 80.9% for those not on cART ( p = 0.002). Women on cART were predominantly of white (40.7%) or African, Caribbean or black (ACB) ethnicities (31.9%) versus women not on cART were primarily of white (46.6%) or indigenous (31.4%) ethnicities ( p < 0.001). Among women on cART, 91.0% women reported an undetectable VL versus 39.9% for those not on cART ( p < 0.001).
Factors associated with not currently being on cART (n = 204) compared with those currently on cART (n = 1178) Table 2 shows the unadjusted and adjusted odds ratio (aOR) of not currently being on cART compared with those currently on cART. In unadjusted analyses, being younger than or equal to 25 years of age or 26-34 years of age versus >35, of sexual minority status versus heterosexual, selling drugs, panhandling, or sex work as the main source of income versus a paid job, having less than two financial dependents versus two to three, unstable housing versus owning, food insecurity, current IDU, having greater social support and higher HIV-related stigma, and racial as well as gender discrimination, were all associated with increased odds of not being on cART. Persons of ACB ethnicity versus white/ Caucasian, having less than a secondary education versus a postsecondary education, acquiring HIV through nonconsensual sex, sharing needles, or through blood transfusion/ other medical procedures versus consensual sex, being diagnosed with HIV between 6 and 14 years ago or >14 years ago versus <6 years ago, and depression were associated with reduced odds of not being on cART. Of the 1178 women on cART, 91.0% had an undetectable VL and 9.0% had detectable VLs. Table 3 shows the unadjusted and aOR of having a self-reported detectable VL compared with an undetectable VL among women on cART. In univariate logistic regression analyses, factors associated with higher odds of having a self-reported detectable VL among women on cART included the following: being 25 years of age or younger versus 35 years of age, of sexual minority status versus heterosexual, indigenous versus white/ Caucasian, having less than a secondary or a secondary education versus postsecondary, having any source of income (except savings/loan/family) versus a paid job, earning between $20,000 and $40,000 per year versus greater than $40,000 per year, renting or unstable housing versus owning, food insecurity, incarceration ever or last year versus never, current IDU, and depression. Factors associated with lower odds of having a detectable VL among women on cART included the following: ACB versus white/Caucasian ethnicity and having more than three financial dependents versus two to three. In multivariable analysis, factors associated with significantly increased odds of having a self-reported detectable VL among women on cART included age (being younger than the age of 25 These findings have important implications for both individual WLWH and for healthcare policies and practices in Canada. Despite the current international guidelines recommending early initiation of cART, *15% of Canadian WLWH were not currently on cART. 7 This may, in part, be explained by having used baseline data from WLWH as early as 2013, at which point cART was still being prescribed based on a CD4 count cutoff of <500 cells/lL. 41 In fact, 42.4% of women who were not on cART reported a CD4 cell count of >500 cells/lL, indicating that there was a sizeable proportion of women who were not on cART due to medical ineligibility at the time of interview. As such, our findings may by underestimating the true proportion of WLWH who were on cART. Another plausible explanation is that some of the women not on cART represented elite controllers or long-term nonprogressors (*40% of these women reported suppressed VLs). Since current guidelines fail to make strong recommendations for or against cART in this population, the majority of elite controllers remain off cART. 7 However, more recently, experts have been recommending cART for elite controllers due to inflammatory cardiovascular benefits. 42, 43 Other WLWH may have chosen not to take cART for various reasons such as concomitant substance abuse, self-stigma, depression, or previous negative experiences with drug toxicities. [44] [45] [46] It may be worthwhile exploring women's and provider's knowledge and providers' prescribing practices following the revised guidelines as there may be a role for provider education regarding updated ART initiation guidelines.
Addressing some key sociodemographic and psychosocial correlates may help ensure that all WLWH are accessing and taking cART. Women who reported current IDU had the highest odds of not being on cART. While this may reflect less frequent contact with the healthcare system, evidence suggests WLWH with a known history of substance use are less likely to be prescribed cART by their providers due to provider-related stigma or fear of poor adherence and its consequences on resistance. 12 Further, in our study, WLWH who endorsed racial discrimination had higher odds of not taking cART. These findings have broader implications for ongoing efforts in reducing harm associated with substance use and racial stigma and discrimination both at a structural and at a provider level. In addition, young WLWH (aged [26] [27] [28] [29] [30] [31] [32] [33] [34] had an almost twofold greater risk of not being on cART. This finding raises important questions about young women's understanding of the importance of cART, as well as provider's understanding of the needs of younger women. 18 In the end, food insecurity was found to be associated with higher odds of not being on cART, a finding that is likely associated with multiple factors. Food is often required for cART use and if not required, many women indicate that they get nauseated when taking cART without food. 46 Also, food insecurity has been associated with poorer decision-making. 47 Finally, food insecurity is likely a surrogate marker for poverty. A better understanding of the way poverty and food insecurity affects cART use and access may be useful to moving forward.
Our study findings outlining the correlates associated with viremia despite cART use parallel what has already been described in the literature. 12, 13 We found that young WLWH (£25 years and between 26 and 34 years of age) were two to three times more likely to report detectable VLs on cART; decreasing age was directly proportional to increased risk of VL detectability. This presumably reflects issues with medication adherence (or due to lack of cART use in the 26-to 34-year-old age category), likely due to competing factors such as substance use, depression, and access among many others. This finding reinforces the need for youth-and young adult-focused programs, as well as the prescription of singletablet regimens containing third agents with high barriers to resistance to optimize adherence and minimize drug resistance. 48 We also found that WLWH who had less than a high school education had 2.5-fold higher odds reporting detectable VLs on cART. Exploring the role of education to assist with VL suppression for WLWH may be necessary as the downstream effects of low education such as poverty and nonadherence are palpable correlates associated with viral detectability. Further, education captures the effect of childhood and young adulthood resource disparities, which may have long-term health consequences. The negative health effects of chronic stress brought on by poverty may be one area of inquiry. Finally, a history of incarceration in the previous year was associated with an almost threefold increased risk of VL detectability. This is likely due to treatment interruption or difficulties maintaining adherence during the time of or just after incarceration, and is crucial to rectify through structural system changes. 49 A major social determinant of health affecting cART use and VL suppression that emerged from our study was housing insecurity. Women with unstable housing had 2.5 and over fivefold higher odds of not taking cART and reporting detectable VLs on cART, respectively, adding to current evidence that unstable housing is significantly associated with decreased care along the continuum of HIV care. 50, 51 Housing insecurity may itself reduce access to care, and, in addition, be a reflection of the interaction of complex social forces such as substance use, as well as poverty, lower education level, presence of mental health issues, and adverse childhood experiences among other possible contributing factors. 26, 52, 53 Research and programming focusing on women who are marginally housed may consider developing partnerships with and providing referrals to organizations that address housing needs in addition to other intersecting factors such as substance use and food insecurity. 36 Recognizing the role that structural barriers have on the HIV care continuum has implications for addressing the social determinants of health when planning programmatic efforts to address attrition along the cascade of care for WLWH.
There are a few limitations to note related to this analysis and the overall study design. Importantly, a biological outcome such as VL would best be measured utilizing blood testing. However, we used self-reported VL at most recent visit, which is subject to recall and social desirability bias. To mitigate this concern, analyses were conducted to explore the validity of our self-reported VL measure, and we found a high degree of correlation between self-reported and laboratory VLs. 54 The use of venue-based sampling-whereby many participants were recruited from ASOs, CBOs, and HIV clinics-may have introduced a selection bias, whereby we overestimated the proportion of women on cART (K. Webster, et al., unpublished observations). However, several steps were taken to ensure adequate representation of women who experience multiple forms of social and structural marginalization (e.g., women who use substances, women who do sex work, ands young women) who may be outside of care. 27 Therefore, on the contrary, word-of-mouth and purposive sampling may have overestimated those not on cART. The results in this analysis are not generalizable to all Canadian WLWH and must be taken in context of the nonrandom sampling. In addition, women not on cART were a combination of women who had not yet initiated cART and women who had used cART previously but not currently, leading to potential for misclassification. Ideally, a separate analysis would have been conducted for each group, but we combined these two categories due to small sample sizes. Finally, the cross-sectional study design does not allow for the establishment of causality, and reverse causality is an issue with regard to some factors (e.g., having a detectable VL could be a function of poor overall HIV-related health, which may influence poverty, rather than poverty influencing VL). Thus, some results should be interpreted with caution.
In conclusion, our study highlights several important sociodemographic, psychosocial, and clinical care factors associated with a lack of cART use and VL detection despite cART use in a large cohort of Canadian WLWH. Programmatic efforts to improve cART access and use for WLWH in Canada should focus on young women (<35 years of age), women with low levels of education or food and housing insecurity, as well as those who use drugs and have a history of incarceration. If these important social determinants of health can be considered, addressed, and modified, great strides will be made to ensure that Canadian WLWH reap the full benefits of cART.
